Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01930617
Other study ID # 2011/2050
Secondary ID
Status Completed
Phase N/A
First received August 22, 2013
Last updated June 24, 2017
Start date June 2014
Est. completion date December 2016

Study information

Verified date June 2017
Source St. Olavs Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

There are numerous reported ways to treat chronic subdural hematomas (CSDH) and practice is still differing considerably between departments. Except for a recent randomized controlled trial (RCT) that found that postoperative subdural drainage was better than no drain, there is no higher level evidence. Another recent RCT did not replicate these findings, but the study was severely underpowered.

Aim of this population based study is to compare clinical results (reoperation rates, complications, perioperative death, and survival) between neurosurgical departments treating CSDH with different treatment policies.


Recruitment information / eligibility

Status Completed
Enrollment 1258
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- All patients treated with evacuation of primary chronic subdural hematoma(CSDH) from 2005 through 2010 at St.Olav University Hospital

- All patients treated with evacuation of primary chronic subdural hematoma(CSDH) from 2005 through 2010 at University Hospital North Norway

- All patients treated with evacuation of primary CSDH from 2006 through 2010 at Karolinska University Hospital (not 2005 due to practical reasons since major changes occurred in electronic surgery protocols 2005).

Exclusion Criteria:

- Chronic subdural hematoma in arachnoid cyst(s)

- Previous CSDH surgery

- External hydrocephalus (hydrocephalus with cerebrospinal fluid (CSF) in the subdural space rather than in the ventricles)

- CSDH due to previous intracranial surgery (within 6 months).

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Burr hole surgery with various drainage techniques
Surgical technique Continuous irrigation and drainage Passive subdural drain Active subgaleal drain

Locations

Country Name City State
Norway University Hospital of North Norway Tromsø
Norway St Olavs Hospital Trondheim
Sweden Karolinska University Hospital Stockholm

Sponsors (4)

Lead Sponsor Collaborator
St. Olavs Hospital Karolinska Institutet, Norwegian University of Science and Technology, University Hospital of North Norway

Countries where clinical trial is conducted

Norway,  Sweden, 

References & Publications (1)

Sjåvik K, Bartek J Jr, Sagberg LM, Henriksen ML, Gulati S, Ståhl FL, Kristiansson H, Solheim O, Förander P, Jakola AS. Assessment of drainage techniques for evacuation of chronic subdural hematoma: a consecutive population-based comparative cohort study. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary reoperations Number of reoperations (X/N, %) between centers 1 year
Secondary continuous irrigation versus other drainage Number of reoperations with use of continuous irrigation (UNN) versus other drainage (St.Olav, Karolinska) 1 year
Secondary perioperative death 30 days
Secondary survival Minimum 3 years follow up. Report 1 year mortality and use of Kaplan Meier curves (log rank test) 3 years
Secondary surgical complications As defined by the Ibanez classification where it is the treatment given for a complication that gives the score. Medical and surgical complication is both mentioned and reported seperately 30 days
See also
  Status Clinical Trial Phase
Recruiting NCT04742920 - The Onyx™ Trial For The Embolization Of The Middle Meningeal Artery For Chronic Subdural Hematoma (OTEMACS) N/A
Recruiting NCT05327933 - Preventing Recurrences of Chronic Subdural Hematoma in Adult Patients by Middle Meningeal Artery Embolization N/A
Recruiting NCT05426889 - The Role of Meningeal Lymphatic Vessels in the Absorption of Chronic Subdural Hematoma and Its Injury Mechanism N/A
Recruiting NCT03582293 - Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma Phase 3
Terminated NCT00915928 - Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme Inhibitors N/A
Completed NCT03755349 - Covers to Improve Esthetic Outcome After Surgery for Chronic Subdural Hematoma N/A
Terminated NCT02362321 - Role of Dexamethasone in the Conservative Treatment of Chronic Subdural Hematoma Phase 4
Recruiting NCT04573387 - Exhaustive Drainage Versus Fixed-time Drainage for Chronic Subdural Hematoma After One-burr Hole Craniostomy N/A
Withdrawn NCT03845322 - Curcumin/Turmeric as a Treatment for Patients With Subdural Hematomas Recurrence Early Phase 1